Geode Capital Management
NKTR icon

Geode Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.42M Sell
132,373
-3,876,751
-97% -$100M ﹤0.01% 2923
2025
Q1
$2.73M Buy
4,009,124
+51,538
+1% +$35.1K ﹤0.01% 2932
2024
Q4
$3.68M Sell
3,957,586
-5,497
-0.1% -$5.11K ﹤0.01% 2890
2024
Q3
$5.15M Sell
3,963,083
-149,416
-4% -$194K ﹤0.01% 2743
2024
Q2
$5.1M Buy
4,112,499
+2,059,414
+100% +$2.55M ﹤0.01% 2706
2024
Q1
$1.92M Buy
2,053,085
+13,471
+0.7% +$12.6K ﹤0.01% 3127
2023
Q4
$1.15M Buy
2,039,614
+84,258
+4% +$47.6K ﹤0.01% 3302
2023
Q3
$1.16M Buy
1,955,356
+59,382
+3% +$35.4K ﹤0.01% 3260
2023
Q2
$1.09M Sell
1,895,974
-1,622,102
-46% -$933K ﹤0.01% 3316
2023
Q1
$2.47M Buy
3,518,076
+74,365
+2% +$52.3K ﹤0.01% 2942
2022
Q4
$7.78M Buy
3,443,711
+117,721
+4% +$266K ﹤0.01% 2423
2022
Q3
$10.6M Buy
3,325,990
+72,027
+2% +$230K ﹤0.01% 2202
2022
Q2
$12.4M Buy
3,253,963
+800,499
+33% +$3.04M ﹤0.01% 2104
2022
Q1
$13.2M Buy
2,453,464
+95,811
+4% +$516K ﹤0.01% 2157
2021
Q4
$31.9M Sell
2,357,653
-3,166
-0.1% -$42.8K ﹤0.01% 1654
2021
Q3
$42.4M Sell
2,360,819
-28,311
-1% -$508K 0.01% 1416
2021
Q2
$41M Buy
2,389,130
+62,401
+3% +$1.07M 0.01% 1480
2021
Q1
$46.5M Buy
2,326,729
+40,953
+2% +$819K 0.01% 1285
2020
Q4
$38.9M Buy
2,285,776
+201,442
+10% +$3.42M 0.01% 1289
2020
Q3
$34.6M Sell
2,084,334
-73,798
-3% -$1.22M 0.01% 1126
2020
Q2
$50M Buy
2,158,132
+46,960
+2% +$1.09M 0.01% 896
2020
Q1
$37.7M Buy
2,111,172
+71,526
+4% +$1.28M 0.01% 918
2019
Q4
$44M Sell
2,039,646
-775,226
-28% -$16.7M 0.01% 1032
2019
Q3
$51.2M Buy
2,814,872
+93,359
+3% +$1.7M 0.01% 872
2019
Q2
$96.7M Buy
2,721,513
+323,432
+13% +$11.5M 0.02% 576
2019
Q1
$80.4M Buy
2,398,081
+163,885
+7% +$5.5M 0.02% 627
2018
Q4
$73.3M Buy
2,234,196
+5,158
+0.2% +$169K 0.02% 576
2018
Q3
$136M Buy
2,229,038
+281,776
+14% +$17.1M 0.04% 442
2018
Q2
$94.9M Sell
1,947,262
-95,097
-5% -$4.63M 0.03% 533
2018
Q1
$217M Buy
2,042,359
+596,388
+41% +$63.3M 0.07% 276
2017
Q4
$86.4M Buy
1,445,971
+13,958
+1% +$834K 0.03% 528
2017
Q3
$34.4M Buy
1,432,013
+51,656
+4% +$1.24M 0.01% 876
2017
Q2
$27M Buy
1,380,357
+40,253
+3% +$787K 0.01% 989
2017
Q1
$31.5M Buy
1,340,104
+151,369
+13% +$3.55M 0.01% 860
2016
Q4
$14.6M Buy
1,188,735
+184,784
+18% +$2.27M 0.01% 1321
2016
Q3
$17.2M Buy
1,003,951
+13,116
+1% +$225K 0.01% 1101
2016
Q2
$14.1M Buy
990,835
+11,045
+1% +$157K 0.01% 1175
2016
Q1
$13.5K Buy
979,790
+72,107
+8% +$991 0.01% 1173
2015
Q4
$15.3M Buy
907,683
+35,653
+4% +$601K 0.01% 1069
2015
Q3
$9.56M Buy
872,030
+30,115
+4% +$330K 0.01% 1374
2015
Q2
$10.5M Buy
841,915
+27,657
+3% +$346K 0.01% 1390
2015
Q1
$8.96M Buy
814,258
+65,937
+9% +$725K 0.01% 1470
2014
Q4
$11.6M Buy
748,321
+12,071
+2% +$187K 0.01% 1207
2014
Q3
$8.89M Buy
736,250
+8,425
+1% +$102K 0.01% 1356
2014
Q2
$9.33M Buy
727,825
+28,426
+4% +$364K 0.01% 1350
2014
Q1
$8.48M Buy
699,399
+122,770
+21% +$1.49M 0.01% 1369
2013
Q4
$6.54M Buy
576,629
+58,536
+11% +$664K ﹤0.01% 1493
2013
Q3
$5.41M Buy
518,093
+15,580
+3% +$163K ﹤0.01% 1504
2013
Q2
$5.8M Buy
+502,513
New +$5.8M 0.01% 1300